| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $893K+1075.0% | $76K | $0 | $0 | — |
| Research and development | $114.1M-10.6% | $127.7M+19.6% | $106.7M+30.0% | $82.1M+77.4% | $46.3M |
| General and administrative | $51.8M-7.7% | $56.1M+25.1% | $44.8M-36.8% | $70.9M+701.1% | $8.9M |
| Total operating expenses | $165.9M-9.7% | $183.8M+21.3% | $151.5M-1.0% | $153.0M+177.6% | $55.1M |
| Operating loss | -$165.0M+10.2% | -$183.7M-21.2% | -$151.5M+1.0% | -$153.0M-177.6% | -$55.1M |
| Interest income | $13.8M-30.1% | $19.8M-10.6% | $22.1M+269.1% | $6.0M+299050.0% | $2K |
| Interest expense | -$4K+55.6% | -$9K+25.0% | -$12K+94.4% | -$215K | $0 |
| Net loss before income taxes | -$151.2M+7.8% | -$163.9M-26.6% | -$129.5M+12.1% | -$147.2M-167.2% | -$55.1M |
| Income tax (benefit) expense | $414K+169.2% | -$598K-110.0% | $6.0M+569.2% | $896K+2257.9% | $38K |
| Net loss before noncontrolling interest | -$151.6M+7.2% | -$163.3M-20.6% | -$135.4M+8.6% | -$148.1M-168.6% | -$55.1M |
| Net loss attributable to noncontrolling interest | -$82.6M+19.1% | -$102.1M-2.2% | -$100.0M-149.3% | -$40.1M | $0 |
| Net loss available to Class A ordinary shareholders | -$69.0M-12.7% | -$61.2M-72.5% | -$35.5M+67.2% | -$108.0M-95.9% | -$55.1M |
| Common Class A [Member] | |||||
| Weighted average Class A ordinary shares outstanding, Basic | 133.94B+36.8% | 97.92B+58.7% | 61.71B+0.3% | 61.54B | — |
| Weighted average Class A ordinary shares outstanding, Diluted | 133.94B+36.8% | 97.92B+58.7% | 61.71B+0.3% | 61.54B | — |
| Net loss per share attributable to Class A ordinary shares, Basic | -$0.52+16.1% | -$0.62-8.8% | -$0.57-147.8% | -$0.23 | — |
| Net loss per share attributable to Class A ordinary shares, Diluted | -$0.52+16.1% | -$0.62-8.8% | -$0.57-147.8% | -$0.23 | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.